Table 1.
Individual baseline characteristics
| Patient ID |
Sex/age (years) | Diagnosis | Anatomy | Time since last intestinal resection (years) | SBS classification | Concomitant medication | Parenteral Support | Body weight | BMI | Dietary intake | Faecal output | Wet weight absorption | Urine production | ||||||
| SB length (cm) | Colon | IF/II | Proton pump inhibitor | Codeine | Loperamide | Fluid (ml/day) | (kg) | (kg/m2) | Wet weight (g/day) | Energy (MJ/day) | Wet weight (g/day) | Energy (MJ/day) | Absolute (ml/day) |
Relative (%/day) |
(ml/day) | ||||
| 1 | M/68 | Ileus | 50 | Anastomosis with transverse colon | 12 | IF | Yes | Yes | Yes | 1000 | 53.8 | 19.5 | 1737 | 6.4 | 383 | 3.1 | 1353 | 78 | 1520 |
| 2 | M/40 | CD | 65 | Jejuno-ascendo-anastomosis | 15 | IF | No | No | No | 2667 | 74.3 | 24.0 | 3513 | 7.9 | 1990 | 4.6 | 1523 | 43 | 3273 |
| 3 | F/56 | MVD | 85 | Anastomosis with transverse colon | 2.3 | IF | No | No | No | 1833 | 57.8 | 19.5 | 3553 | 13.0 | 3480 | 8.6 | 73 | 2 | 1023 |
| 4 | M/69 | CD | 100 | Anastomosis with transverse colon | 1.5 | IF | Yes | No | No | 3000 | 75.5 | 25.5 | 2997 | 10.9 | 3357 | 5.9 | −360 | −12 | 1692 |
| 5 | M/35 | CD | UK | Ileo-ascendo-anastomosis | 4.6 | II | No | Yes | No | 0 | 73.3 | 19.9 | 4827 | 18.5 | 983 | 6.0 | 3843 | 80 | 2607 |
| 6 | F/20 | MVD | 70 | Anastomosis with transverse colon | 11 | II | No | No | No | 0 | 61.9 | 22.5 | 4353 | 11.2 | 1087 | 4.9 | 3267 | 75 | 2290 |
| 7 | F/43 | CD | 200 | Anastomosis with transverse colon | 5 | II | Yes | Yes | No | 0 | 92.1 | 30.8 | 2973 | 14.4 | 483 | 2.6 | 2490 | 84 | 1177 |
| 8 | M/50 | RC | 190 | Anastomosis with transverse colon | 6 | II | Yes | Yes | No | 0 | 74.5 | 23.0 | 3022 | 10.8 | 460 | 1.7 | 2562 | 85 | 1007 |
BMI, body mass index; CD, Crohn’s Disease; F, female; IF, intestinal failure; II, Intestinal insufficiency; M, male; MVD, mesenteric vascular disease; RC, rectal cancer; SB, small bowel; SBS, short bowel syndrome; UK, unknown.